These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 1463869)
1. In vitro potentiation by lonidamine of the cytotoxic effect of adriamycin on primary and established breast cancer cell lines. Savini S; Zoli W; Nanni O; Volpi A; Frassineti GL; Magni E; Flamigni A; Amadori A; Amadori D Breast Cancer Res Treat; 1992; 24(1):27-34. PubMed ID: 1463869 [TBL] [Abstract][Full Text] [Related]
2. Lonidamine as a modulator of alkylating agent activity in vitro and in vivo. Teicher BA; Herman TS; Holden SA; Epelbaum R; Liu SD; Frei E Cancer Res; 1991 Feb; 51(3):780-4. PubMed ID: 1988117 [TBL] [Abstract][Full Text] [Related]
3. Saporin 6 and lonidamine in primary cell cultures from human breast carcinomas: a synergistic effect. Gasperi-Campani A; Roncuzzi L; Zoli W; Amadori D Anticancer Drug Des; 1997 Mar; 12(2):91-8. PubMed ID: 9113064 [TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo potentiation by lonidamine of the antitumor effect of adriamycin. Zupi G; Greco C; Laudonio N; Benassi M; Silvestrini B; Caputo A Anticancer Res; 1986; 6(5):1245-9. PubMed ID: 3800331 [TBL] [Abstract][Full Text] [Related]
5. Adriamycin resistance modulation induced by lonidamine in human breast cancer cells. Zupi G; Molinari A; D'Agnano I; Meschini S; Del Bufalo D; Matarrese P; Candiloro A; Calcabrini A; Citro G; Arancia G Anticancer Res; 1995; 15(6B):2469-77. PubMed ID: 8669810 [TBL] [Abstract][Full Text] [Related]
6. In vitro effect of lonidamine on the cytotoxicity of mitomycin C and BCNU in human colon adenocarcinoma cells. Villa R; Zaffaroni N; Orlandi L; Bearzatto A; Costa A; Silvestrini R Eur J Cancer; 1994; 30A(10):1534-40. PubMed ID: 7833114 [TBL] [Abstract][Full Text] [Related]
7. Effect of lonidamine on the cytotoxicity of four alkylating agents in vitro. Rosbe KW; Brann TW; Holden SA; Teicher BA; Frei E Cancer Chemother Pharmacol; 1989; 25(1):32-6. PubMed ID: 2590999 [TBL] [Abstract][Full Text] [Related]
8. Comparison of action of the anti-neoplastic drug lonidamine on drug-sensitive and drug-resistant human breast cancer cells: 31P and 13C nuclear magnetic resonance studies. Vivi A; Tassini M; Ben-Horin H; Navon G; Kaplan O Breast Cancer Res Treat; 1997 Mar; 43(1):15-25. PubMed ID: 9065595 [TBL] [Abstract][Full Text] [Related]
9. Cytotoxicity of lonidamine alone and in combination with other drugs against murine RIF-1 and human HT1080 cells in vitro. Ning SC; Hahn GM Cancer Res; 1990 Dec; 50(24):7867-70. PubMed ID: 2253227 [TBL] [Abstract][Full Text] [Related]
10. An adriamycin-resistant subline is more sensitive than the parent human small cell lung cancer cell line to lonidamine. Kiura K; Ohnoshi T; Ueoka H; Takigawa N; Tabata M; Segawa Y; Shibayama T; Kimura I Anticancer Drug Des; 1992 Dec; 7(6):463-70. PubMed ID: 1337430 [TBL] [Abstract][Full Text] [Related]
11. In vitro potentiation by lonidamine of the sc-RIP saporin 6 effect in a human metastatic breast cancer cell line. Roncuzzi L; Zoli W; Bajorko P; Gasperi-Campani A Anticancer Res; 1995; 15(3):773-6. PubMed ID: 7645957 [TBL] [Abstract][Full Text] [Related]
12. Lonidamine induces apoptosis in drug-resistant cells independently of the p53 gene. Del Bufalo D; Biroccio A; Soddu S; Laudonio N; D'Angelo C; Sacchi A; Zupi G J Clin Invest; 1996 Sep; 98(5):1165-73. PubMed ID: 8787680 [TBL] [Abstract][Full Text] [Related]
13. The effect of lonidamine alone and in combination with cisplatin on in vitro growth and viability of lung squamous cell carcinoma cell lines. Raaphorst GP; Ko D; Feeley MM; Danjoux CE; Maroun J; Evans WK Anticancer Res; 1991; 11(1):41-7. PubMed ID: 2018379 [TBL] [Abstract][Full Text] [Related]
14. Lonidamine induces intracellular tumor acidification and ATP depletion in breast, prostate and ovarian cancer xenografts and potentiates response to doxorubicin. Nath K; Nelson DS; Heitjan DF; Leeper DB; Zhou R; Glickson JD NMR Biomed; 2015 Mar; 28(3):281-90. PubMed ID: 25504852 [TBL] [Abstract][Full Text] [Related]
15. Reversal of adriamycin resistance by lonidamine in a human breast cancer cell line. Citro G; Cucco C; Verdina A; Zupi G Br J Cancer; 1991 Sep; 64(3):534-6. PubMed ID: 1911196 [No Abstract] [Full Text] [Related]
16. Modulation by lonidamine on the combined activity of cisplatin and epidoxorubicin in human breast cancer cells. Silvestrini R; Gornati D; Zaffaroni N; Bearzatto A; De Marco C Breast Cancer Res Treat; 1997 Jan; 42(2):103-12. PubMed ID: 9138599 [TBL] [Abstract][Full Text] [Related]
17. The in vitro effects of lonidamine combined with cisplatin in human small cell lung cancer cell lines. Ko D; Raaphorst GP; Feeley MM; Danjoux CE; Maroun JA; Evans WK Anticancer Res; 1991; 11(1):235-9. PubMed ID: 1850216 [TBL] [Abstract][Full Text] [Related]
18. Effect of the antitumor drug lonidamine on glucose metabolism of adriamycin-sensitive and -resistant human breast cancer cells. Fanciulli M; Valentini A; Bruno T; Citro G; Zupi G; Floridi A Oncol Res; 1996; 8(3):111-20. PubMed ID: 8823807 [TBL] [Abstract][Full Text] [Related]
19. Efficacy of lonidamine combined with different DNA-damaging agents in the treatment of the MX-1 tumor xenograft. Pratesi G; De Cesare M; Zunino F Cancer Chemother Pharmacol; 1996; 38(2):123-8. PubMed ID: 8616901 [TBL] [Abstract][Full Text] [Related]
20. [Toremifene sensitized the effect of adriamycin on human breast cancer cell lines]. Nakagomi H; Furuya K; Hagiwara J; Nishio T; Watanabe K; Muto S; Takano K; Tada Y Gan To Kagaku Ryoho; 1998 Apr; 25 Suppl 3():454-8. PubMed ID: 9589052 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]